Venus Remedies Limited — Epirubicin Exporter Profile
Indian Pharmaceutical Exporter · #2 for Epirubicin · $1.2M export value · DGFT Verified
Venus Remedies Limited is the #2 Indian exporter of Epirubicin with $1.2M in export value and 56 verified shipments. Venus Remedies Limited holds a 18.7% market share in Epirubicin exports across 12 countries. The company exports 29 pharmaceutical products worth $86.4M across 6 therapeutic categories.
Venus Remedies Limited — Epirubicin Export Profile: Buyers & Destinations
Where Does Venus Remedies Limited Export Epirubicin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MOROCCO | $609.5K | 21 | 67.0% |
| MALAYSIA | $200.0K | 4 | 22.0% |
| PHILIPPINES | $30.5K | 4 | 3.4% |
| VIETNAM, DEMOCRATIC REP. OF | $21.6K | 13 | 2.4% |
| INDONESIA | $20.3K | 3 | 2.2% |
| MOLDOVA,REPUBLIC OF | $10.9K | 1 | 1.2% |
| VENEZUELA | $8.9K | 3 | 1.0% |
| TANZANIA | $3.5K | 3 | 0.4% |
| KUWAIT | $2.5K | 1 | 0.3% |
| NAMBIA | $2.0K | 1 | 0.2% |
Venus Remedies Limited exports Epirubicin to 12 countries. The largest destination is MOROCCO accounting for 67.0% of Venus Remedies Limited's Epirubicin shipments, followed by MALAYSIA (22.0%) and PHILIPPINES (3.4%). These destinations reflect Venus Remedies Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Epirubicin from Venus Remedies Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| P P | MOROCCO | $332.0K | 10 |
| PHARMAPROM | MOROCCO | $192.2K | 8 |
| U S B | MALAYSIA | $150.0K | 3 |
| M.E.L.S.B | MALAYSIA | $50.0K | 1 |
| P P PHARMAPROMROUTE DEL JADIDA KM | MOROCCO | $41.9K | 1 |
| PHARMAPROM ROUTE DEL JADIDAKM | MOROCCO | $30.2K | 1 |
| PT MEGA LIFESCIENCES INDONESIA | INDONESIA | $20.3K | 3 |
| VIETNAM MEDICAL PRODUCTS IMPORT - | VIETNAM, DEMOCRATIC REP. OF | $20.2K | 1 |
| B P D & C C | PHILIPPINES | $15.7K | 2 |
| BLISS PHARMA DISTRIBUTION & | PHILIPPINES | $14.8K | 2 |
Venus Remedies Limited supplies Epirubicin to 22 buyers globally. The largest buyer is P P (MOROCCO), followed by PHARMAPROM (MOROCCO) and U S B (MALAYSIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Epirubicin Export Value and How Much Does Venus Remedies Limited Contribute?
India exported $5.5M worth of Epirubicin through 763 shipments from 156 suppliers to 92 countries, serving 296 buyers globally. Venus Remedies Limited contributes $1.2M to this total, accounting for 18.7% of India's Epirubicin exports. Venus Remedies Limited ships Epirubicin to 12 countries through 22 buyers.
What Is the Average Shipment Value for Venus Remedies Limited's Epirubicin Exports?
Venus Remedies Limited's average Epirubicin shipment value is $21.5K per consignment, based on 56 shipments totaling $1.2M. The largest destination is MOROCCO (67.0% of Venus Remedies Limited's Epirubicin exports).
How Does Venus Remedies Limited Compare to Other Indian Epirubicin Exporters?
Venus Remedies Limited ranks #2 among 156 Indian Epirubicin exporters with a 18.7% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($1.3M), VENUS REMEDIES LIMITED ($1.2M), FRESENIUS KABI ONCOLOGY LIMITED ($1.1M). Venus Remedies Limited processed 56 shipments to 12 destination countries.
What Epirubicin Formulations Does Venus Remedies Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| EPIROL 50MG (EPIRUBICIN HYDROCHLORIDE FO | $62.7K | 4 |
| EPIROL 50MG EPIRUBICIN HYDROCHLORIDE FO | $62.2K | 2 |
| EPIROL 50MG EPIRUBICIN HYDROCHLORIDE FORINJECTION B NO X3AC022C MD 01 2023 ED 12 2024 B NO X3BC012A M 02 2023 E 01 2025 | $50.0K | 1 |
| EPIROL (EPIRUBICIN HYDROCHLORIDE POWDERFOR SOLUTION FOR INJECTION)NOS | $50.0K | 1 |
| EPIROL 50 MG EPIRUBICIN HYDROCHLORIDE POWDER FOR SOLUTION FOR INJECTION 50MG BATCH NO.X4BEP072A,X4BEP082A,X4BEP092A, | $50.0K | 1 |
| EPIROL (EPIRUBICIN HYDROCHLORIDE POWDERFOR SOLUTION FOR INJECTION 50MG) | $50.0K | 1 |
| EPIRUBICIN HYDROCHLORIDE FOR INJ.(EPIROL 50MG) B.NO.X4BEP062CX4BEP112BX4BEP122A MD.02/24 ED.01/26. | $50.0K | 1 |
| EPIRUBICIN HYDROCHLORIDE POWDER FOR SOLUTION FOR INJECTION 50 MG (EPIROL 50 MG) | $50.0K | 1 |
| EPIRUBICIN HYDROCHLORIDE FOR INJECTION EPIROL 50MG BN.X5CEP092B,X5CEP102A,X5CEP112A MFG. DT. 03/2025, EXP. DT. 02/2027 | $50.0K | 1 |
| EPIRUBICIN HYDROCHLORIDE FOR INJECTION EPIROL 50MG BN X5CEP092B X5CEP102A X5CEP112A MFG DT 03 2025 EXP DT 02 2027 | $50.0K | 1 |
Venus Remedies Limited exports 38 distinct Epirubicin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EPIROL 50MG (EPIRUBICIN HYDROCHLORIDE FO with 4 shipments worth $62.7K.
How Does Venus Remedies Limited Compare to Nearest Epirubicin Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $1.3M | 25 | 2 | $50.0K |
| 2 | VENUS REMEDIES LIMITED ★ | $1.2M | 56 | 12 | $21.5K |
| 3 | FRESENIUS KABI ONCOLOGY LIMITED | $1.1M | 42 | 7 | $25.8K |
| 4 | NAPROD LIFE SCIENCES PRIVATE LIMITED | $870.1K | 23 | 10 | $37.8K |
Venus Remedies Limited ranks #2 among 156 Indian Epirubicin exporters. Average shipment value of $21.5K compared to the market average of $35.4K. The closest competitors by value are MYLAN LABORATORIES LIMITED and FRESENIUS KABI ONCOLOGY LIMITED.
Which Indian Ports Ship Epirubicin Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 141 | 18.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 127 | 16.6% |
| SAHAR AIR | 115 | 15.1% |
| DELHI AIR | 99 | 13.0% |
| Bombay Air | 36 | 4.7% |
| AHEMDABAD AIR | 31 | 4.1% |
| Delhi Air | 23 | 3.0% |
| AHEMDABAD AIR ACC (INAMD4) | 22 | 2.9% |
What Other Advanced Oncology Products Does Venus Remedies Limited Export?
Venus Remedies Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Venus Remedies Limited's Epirubicin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Venus Remedies. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and costs for exports to Europe and the Americas. Such disruptions necessitate strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost-effectiveness.
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their presence in the U.S. market. India now supplies 40% of the U.S.'s generic drug needs, reflecting a growing reliance on Indian manufacturers. (ibef.org) Venus Remedies' recent QIDP designation from the U.S. FDA for VRP-034 positions the company favorably to leverage this opportunity, potentially enhancing its market share in the U.S.
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains critical. Venus Remedies' renewal of the EU-GMP certification indicates their proactive approach to meeting stringent EU regulations, thereby ensuring continued access to European markets. (business-standard.com)
Venus Remedies Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Venus Remedies has demonstrated a consistent commitment to quality, as evidenced by multiple GMP certifications. In addition to the EU-GMP renewal, the company secured GMP certification from Moldova's Ministry of Health in January 2025, covering their antibiotic-carbapenem manufacturing facility. (apnnews.com) Furthermore, the renewal of Ukrainian GMP certification in May 2025 for their Baddi facility underscores their adherence to global quality standards. (apnnews.com)
These certifications not only facilitate market access but also enhance the company's reputation as a reliable supplier of high-quality pharmaceuticals. In an industry where regulatory compliance is closely scrutinized, Venus Remedies' proactive measures position them favorably among global competitors.
About Venus Remedies Limited
Venus Remedies Limited exports 29 products worth $86.4M. Beyond Epirubicin, top products include Meropenem, Imipenem, Enoxaparin, Ceftriaxone, Paclitaxel. View the complete Venus Remedies Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Epirubicin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Epirubicin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Venus Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 57 individual customs records matching Venus Remedies Limited exporting Epirubicin, covering 38 formulations to 12 countries via 22 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 92+ countries, 296+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Epirubicin Export Data from Venus Remedies Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Venus Remedies Limited's Epirubicin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Venus Remedies Limited
Full Company Profile →
29 products · $86.4M total trade · 6 categories
Epirubicin Stats
Company Overview
Top Products by Venus Remedies Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Venus Remedies Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Epirubicin. For current shipment-level data, contact TransData Nexus.